Unknown

Dataset Information

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells.


ABSTRACT:

Background

Patients with advanced hematologic malignancies remain at risk for relapse following reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (allo-HSCT). We conducted a prospective clinical trial to test whether vaccination with whole leukemia cells early after transplantation facilitates the expansion of leukemia-reactive T cells and thereby enhances antitumor immunity.

Methods

We enrolled 22 patients with advanced chronic lymphocytic leukemia (CLL), 18 of whom received up to 6 vaccines initiated between days 30 and 45 after transplantation. Each vaccine consisted of irradiated autologous tumor cells admixed with GM-CSF-secreting bystander cells. Serial patient PBMC samples following transplantation were collected, and the impact o

SUBMITTER: Burkhardt UE 

PROVIDER: S-EPMC3754265 | biostudies-literature | 2013 Sep

REPOSITORIES: biostudies-literature